These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 1905501)

  • 61. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
    Dajani EZ; Agrawal NM
    J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gastric colonization as a consequence of stress ulcer prophylaxis: a prospective, randomized trial.
    Ortiz JE; Sottile FD; Sigel P; Nasraway SA
    Pharmacotherapy; 1998; 18(3):486-91. PubMed ID: 9620099
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Sucralfate in the treatment and prevention of gastric ulcer: multicentre double blind placebo controlled study.
    Blum AL; Bethge H; Bode JC; Domschke W; Feurle G; Hackenberg K; Hammer B; Hüttemann W; Jung M; Kachel G
    Gut; 1990 Jul; 31(7):825-30. PubMed ID: 2196208
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of D-002, a product isolated from beeswax, on gastric symptoms of patients with osteoarthritis treated with piroxicam: a pilot study.
    Illnait J; Terry H; Más R; Fernández L; Carbajal D
    J Med Food; 2005; 8(1):63-8. PubMed ID: 15857212
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Misoprostol in treatment of gastropathy due to nonsteroidal anti-inflammatory drugs.
    Blackburn WD; Alarcon GS
    Am J Med; 1990 Jan; 88(1):85. PubMed ID: 2104742
    [No Abstract]   [Full Text] [Related]  

  • 66. Efficacy and tolerability of pantoprazole compared with misoprostol for the prevention of NSAID-related gastrointestinal lesions and symptoms in rheumatic patients.
    Stupnicki T; Dietrich K; González-Carro P; Straszak A; Terjung A; Thomas KB; Lühmann R; Fischer R
    Digestion; 2003; 68(4):198-208. PubMed ID: 14707396
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy of prostanoids in the treatment of gastric ulcer.
    Rachmilewitz D
    Clin Invest Med; 1987 May; 10(3):238-42. PubMed ID: 3113800
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prophylaxis and treatment of NSAID-induced gastroduodenal disorders.
    La Corte R; Caselli M; Castellino G; Bajocchi G; Trotta F
    Drug Saf; 1999 Jun; 20(6):527-43. PubMed ID: 10392669
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparative mucosal protective properties of misoprostol, cimetidine, and sucralfate.
    Bauer RF; Bianchi RG; Casler J; Goldstin B
    Dig Dis Sci; 1986 Feb; 31(2 Suppl):81S-85S. PubMed ID: 3080294
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Preventing upper gastrointestinal bleeding in patients receiving nonsteroidal antiinflammatory drugs.
    Elliott DP
    DICP; 1990 Oct; 24(10):954-8. PubMed ID: 2123049
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal mucosal injury: risk factors for serious complications.
    Koch M; Dezi A; Tarquini M; Capurso L
    Dig Liver Dis; 2000 Mar; 32(2):138-51. PubMed ID: 10975790
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
    Koch M
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S54-62. PubMed ID: 10379471
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Misoprostol, a synthetic PGE1 analog, in the treatment of duodenal ulcers. A multicenter double-blind study.
    Brand DL; Roufail WM; Thomson AB; Tapper EJ
    Dig Dis Sci; 1985 Nov; 30(11 Suppl):147S-158S. PubMed ID: 3932048
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Misoprostol in peptic ulcer disease.
    Watkinson G; Akbar FA
    Prostaglandins; 1987; 33 Suppl():78-92. PubMed ID: 3122278
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy of misoprostol (twice daily dosage) in acute healing of duodenal ulcer. A multicenter double-blind controlled trial.
    Bright-Asare P; Sontag SJ; Gould RJ; Brand DL; Roufail WM
    Dig Dis Sci; 1986 Feb; 31(2 Suppl):63S-67S. PubMed ID: 3080291
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Misoprostol and ulcer prophylaxis.
    Shield MJ; Fenn CG
    Lancet; 1989 Jan; 1(8629):98-9. PubMed ID: 2562901
    [No Abstract]   [Full Text] [Related]  

  • 77. [Cost effectiveness of misoprostol therapy in prevention of NSAID-induced stomach ulcers].
    Schwarz B
    Wien Klin Wochenschr; 1995; 107(12):366-72. PubMed ID: 7631507
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prevention of gastroduodenal injury induced by chronic nonsteroidal antiinflammatory drug therapy.
    Graham DY
    Gastroenterology; 1989 Feb; 96(2 Pt 2 Suppl):675-81. PubMed ID: 2642452
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Role of gastric mucosal blood flow in cytoprotection.
    Hui WM; Chen BW; Cho CH; Luk CT; Lam SK
    Digestion; 1991; 48(2):113-20. PubMed ID: 1907933
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A review of mucosal protection by synthetic prostaglandin E analogs against injury by non-steroidal anti-inflammatory agents.
    Lanza FL
    Scand J Gastroenterol Suppl; 1989; 163():36-43. PubMed ID: 2510249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.